100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
CRNA Interview With Complete Solution $9.99   Add to cart

Exam (elaborations)

CRNA Interview With Complete Solution

 2 views  0 purchase
  • Course
  • CRNA
  • Institution
  • CRNA

CRNA Interview With Complete Solution ...

Preview 3 out of 18  pages

  • October 13, 2024
  • 18
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • CRNA
  • CRNA
avatar-seller
Stetson
CRNA Interview With Complete Solution 2024-2025


Norepinephrine MOA-ANSWER A1, A2, B1 agonist.



Primary agent used in distributive shock because it's ability to recruit venous volume
and augment preload, while increasing arterial tone, and increasing cardiac output.



Alpha one causing peripheral smooth muscle contraction. (low dose venous, high dose
venous and arterial).



However, alpha 2 adrenoreceptor agonism paradoxically antagonizes the release of
norepinephrine in the CNS. These receptors are less present in peripheral vasculature
and thus their anti-hypertensive effects are overtaken by A1 agonism.



These alpha effects can increase SVR and thereby increase cardiac workload,
decrease cardiac output, and increase coronary perfusion pressure.



The slight B1 agonism is sufficient to overcome these A1 effects via increased inotropy
and chonotropy and result in a fairly "pure" vasopressor. Increasing contraction of the
heart and increasing AV nodal conduction.



**First line agent in septic shock



Epinephrine MOA - ANSWER A1



A2



B1 - Stimulate Heart Rate through SA node, increase conduction through AV node.

,Increase contractility to ATRIAL and VENTRICULAR cardiac muscle.



B2- Smooth muscle relaxation. Resulting in dilation of the bronchial tree, coronary
arterial dilation. Also plays a role in insulin and glucagon secretion in the pancreas. Also
increases cardiac inotropy/chonotropy



B3 - Increase lypolysis and thermogenesis in brown adipose tissue.



**Cardiogenic shock or other shock states with a cardiac component.

Adjunctive therapy in severe septic shock

IVP in cardiac arrest to augment CPP

IVP while introducing PPV/intubation



Precedex MOA - ANSWER Dexmetatomadine is an alpha 2 adrenoreceptor agonist that
acts both on the presynaptic neuron and postsynaptic neuron. Inihibiting
norepinephrine release pre-synaptically reduces/halts the transmission of pain while
postsynaptically acts to reduce sympathetic tone. The sum of these effects is
anesthesia with analgesia and anxiolysis.



Loading dose is 1 mg/kg while gtt is .2-1.5 mg/kg/hr



This agent is often used for patients who would not tolerate a precipitous drop in their
sympathetic tone, for those patients in severe alcohol withdrawal.



propofol MOA - ANSWER Propofol is a lypophylic general anesthetic unlike any drugs of
the class benodiazapen, barbituate, or A2 agonist. Its mechanism is proposed to be a
GABA (inhibitory neurotransmitter) agonist causing global CNS depression



Dosing for procedural sedation of .1-.5 mg/kg as a loading dose with repeat doses. gtt
titration ranging from 10-60 mcg/kg/min

, **Anesthetic

Sedation for mechanically ventilated ICU patients

Procedural sedation



Phenylephrine MOA - ANSWER Pure Alpha adrenergic receptor agonist. Causing
increase in SVR through systemic arterial vasoconstriction. This also causes a dose
dependent increase in systolic and diastolic blood pressure and thereby decreasing
cardiac output, especially in patients with heart failure.



40-100 mcg IVP for hypotension during anesthesia



Titrated as a drip from .5-9 mcg/kg/min



**used rarely as adjuncitve therapy for patients in septic shock.

Used more often in vasodilatory shock states such as neurogenic shock/ shock from
epidural/spinal blocks.



vasopressin MOA - ANSWER arganine/vasopressin receptor agonist causing potent
increase in SVR through 2 different MOA.

1) regulation of the volume of extracellular fluid through its effects on renal collecting
ducts and distal convoluted tubule to increase water permeability via v2 receptors

2)Sodium re-absorption across the ascending loop of HENLe.

3)Binding to V1 receptors on vascular smooth muscle, producing vasoconstriction.



Normal concentrations of the drug are below it's vasoactive range, however in profound
hypovolemic shock, AVP increases do contribute to increase in SVR.



1.8 u/hr



**used as adjunctive therapy in septic shock. Can be used as a first line agent in a

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Stetson. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $9.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

81849 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$9.99
  • (0)
  Add to cart